CA3242577A1 - Solid forms of pyrazolo[3,4-d]pyrimidine compounds - Google Patents

Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Info

Publication number
CA3242577A1
CA3242577A1 CA3242577A CA3242577A CA3242577A1 CA 3242577 A1 CA3242577 A1 CA 3242577A1 CA 3242577 A CA3242577 A CA 3242577A CA 3242577 A CA3242577 A CA 3242577A CA 3242577 A1 CA3242577 A1 CA 3242577A1
Authority
CA
Canada
Prior art keywords
pyrazolo
solid forms
pyrimidine compounds
pyrimidin
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3242577A
Other languages
English (en)
French (fr)
Inventor
John C. Amedio Jr.
Erika Volckova
Caroline Yvette PROULX-LAFRANCE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CA3242577A1 publication Critical patent/CA3242577A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA3242577A 2021-12-16 2022-12-16 Solid forms of pyrazolo[3,4-d]pyrimidine compounds Pending CA3242577A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290136P 2021-12-16 2021-12-16
US63/290,136 2021-12-16
PCT/US2022/081795 WO2023114995A1 (en) 2021-12-16 2022-12-16 Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
CA3242577A1 true CA3242577A1 (en) 2023-06-22

Family

ID=85172741

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3242577A Pending CA3242577A1 (en) 2021-12-16 2022-12-16 Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Country Status (11)

Country Link
US (2) US12012412B2 (https=)
EP (1) EP4448529A1 (https=)
JP (1) JP2024546844A (https=)
KR (1) KR20240119299A (https=)
CN (1) CN118401525A (https=)
AU (2) AU2022416644B2 (https=)
CA (1) CA3242577A1 (https=)
IL (1) IL313314A (https=)
MX (1) MX2024007517A (https=)
TW (1) TW202333676A (https=)
WO (1) WO2023114995A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12012412B2 (en) * 2021-12-16 2024-06-18 Pfizer Inc. Solid forms of pyrazolo[3,4-d]pyrimidine compounds
AU2024329573A1 (en) * 2023-08-22 2026-04-02 Cardurion Pharmaceuticals, Inc. Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RS52166B (sr) * 2007-05-11 2012-08-31 Pfizer Inc. Amino-heterociklična jedinjenja
CN109893653A (zh) * 2017-12-11 2019-06-18 王慧敏 Pde9抑制剂的新用途
US12012412B2 (en) 2021-12-16 2024-06-18 Pfizer Inc. Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Also Published As

Publication number Publication date
MX2024007517A (es) 2024-08-19
AU2022416644A1 (en) 2024-07-04
NZ812114A (en) 2025-08-29
AU2025275149A1 (en) 2026-01-08
KR20240119299A (ko) 2024-08-06
EP4448529A1 (en) 2024-10-23
TW202333676A (zh) 2023-09-01
CN118401525A (zh) 2024-07-26
IL313314A (en) 2024-08-01
JP2024546844A (ja) 2024-12-26
US12012412B2 (en) 2024-06-18
US20230192707A1 (en) 2023-06-22
WO2023114995A1 (en) 2023-06-22
AU2022416644B2 (en) 2025-09-11
US20240300961A1 (en) 2024-09-12

Similar Documents

Publication Publication Date Title
CA3242577A1 (en) Solid forms of pyrazolo[3,4-d]pyrimidine compounds
BR0314001A (pt) Pirazolopirimidinas como inibidores de cinase dependente de ciclina
WO2007044449A3 (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
CA2388140A1 (en) Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
ATE362474T1 (de) Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
WO2007044401A3 (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
MY137888A (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
WO2005077954A3 (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
AU2003225933A1 (en) AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO(3,4-d) PYRIMIDINES AS KINASE MODULATORS
MY139336A (en) N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
NZ590922A (en) Piperidine derivatives as jak3 inhibitors
WO2007044407A3 (en) Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors
MX2020009586A (es) Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk.
WO2004106340A3 (en) 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
EP1383769A4 (en) PYRAZOLO 3,4-D] PYRIMIDINE-4-ONES 6-SUBSTITUTES USEFUL AS INHIBITORS OF KINASE DEPENDENT CYCLINES
Moszczyński-Pętkowski et al. Synthesis and characterization of novel classes of PDE10A inhibitors-1H-1, 3-benzodiazoles and imidazo [1, 2-a] pyrimidines
PT3801526T (pt) Formas mono-hidratas e cristalinas de 6-[(3s,4s)-4-metil- 1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran- 4-il-7h-imidazo[1,5-a]pirazin-8-ona
AU2002365211A1 (en) 6-substituted pyrazolo (3,4-d) pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
DK0678092T3 (da) 5-alkoxy [1,2,4]triazolo[1,5-c]pyrimidin-2(3H)-thion-forbindelser og anvendelse deraf til fremstilling af 2,2'-dithiobis(5-
MY138201A (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
DE69930416D1 (de) Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion
EP4393924A4 (en) IMIDAZO[1,2-A]PYRAZINE OR PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVE AND USE THEREOF
NZ812114B2 (en) Solid forms of pyrazolo[3,4-d]pyrimidine compounds
HK40117266A (en) Solid forms of pyrazolo[3,4-d]pyrimidine compounds
HK40123927A (en) Triazole-substituted imidazo[1,2-a]pyrimidines as cgas inhibitors

Legal Events

Date Code Title Description
P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20240828

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241205

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241205

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241205

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251210

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251210